Targeting purinergic receptors in glioblastoma with nanobody-displaying AAV vectors
{{output}}
The standard therapy for glioblastoma, surgery followed by radio- and chemotherapy, results in ATP release from damaged and stressed cells. The GPI-anchored ecto-enzyme CD73 and the ATP-gated P2X7 ion channel are often expressed on glioblastoma cells. CD73 con... ...
